Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | pUMVC3-IGFBP2-HER2-IGF1R vaccine |
Synonyms | |
Therapy Description |
pUMVC3-IGFBP2-HER2-IGF1R (WOKVAC) vaccine is a plasmid-based vaccine containing sequences for IGFBP2, ERBB2 (HER2), and IGF1R, which potentially induces immune response against tumors expressing these proteins (Cancer Res February 15 2017 (77) (4 Supplement) OT3-01-03). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
pUMVC3-IGFBP2-HER2-IGF1R vaccine | WOKVAC vaccine|WOKVAC | pUMVC3-IGFBP2-HER2-IGF1R (WOKVAC) vaccine is a plasmid-based vaccine containing sequences for IGFBP2, ERBB2 (HER2), and IGF1R, which potentially induces immune response against tumors expressing these proteins (Cancer Res February 15 2017 (77) (4 Supplement) OT3-01-03). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03384914 | Phase II | HER2-pulsed DC1 vaccine pUMVC3-IGFBP2-HER2-IGF1R vaccine | Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer | Active, not recruiting | USA | 0 |